Explorer
Japan: Remdesivir approved for Coronavirus treatment
The development of Remdesivir had started in 2009 and was used for Ebola patients during the 2000s. The medication was recently given a fast-track approval in Japan for the treatment of Coronavirus patients. Gilead Sciences company that produces Remdesivir, had applied for the approval of this drug only three days ago.
The US is also planning to begin treating seriously ill COVID-19 patients with Remdesivir.
The US is also planning to begin treating seriously ill COVID-19 patients with Remdesivir.
India
Bihar Politics: Rabri Devi Refuses to Vacate Official Bungalow, Challenges Bihar Government Over Eviction Move
Uttar Pradesh News: CM Yogi Adityanath Says Non-Violence Is Supreme, But Action Is Necessary Against Threats
Education News: NTA Apologises After Technical Glitch Delays CUET UG 2026 Exam, Assures Fair Conduct
US-Iran Tensions: Pentagon Chief Issues Stern Warning, Vows to Block Tehran’s Nuclear Ambitions
J&K Weather Alert: Storm Uproots Trees in Gulmarg, Massive Fire Engulfs House in Himachal’s Kullu
View More
Top Headlines
World
US Fires Hellfire Missile To Stop Vessel Bound For Iran In Gulf Of Oman
India
'Rulers Became Killers': Mamata, Rahul React After Attack On Abhishek Banerjee
India
Amit Shah Reviews Sir Creek Border Security, Reiterates Zero Infiltration Policy
News
Jaishankar Holds Talks With Myanmar President, Focus On Connectivity & Trade
